New research by Chongsuk Ryou, researcher at the UK Sanders-Brown Center on Aging and professor of microbiology, immunology and molecular genetics in the UK College of Medicine, may shed light on possible…
Scientists identify strategy for targeted molecular therapy in liver cancer
In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory (CSHL) and four other institutions have identified a strategy for targeted molecular therapy…
New animal model helps define molecular processes that lead to PA
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor, and there are few medical therapies available to those patients for whom surgery is not curative. However, it has been difficult to…
Study provides insight into aging immune system
A study featured on the cover of the March 15 Journal of Immunology is providing insight into why the elderly are so vulnerable to pneumonia and other bacterial infections. The study has…
Heavy alcohol consumption linked to increased risk of death from pancreatic cancer
Heavy alcohol consumption, specifically three or more glasses of liquor a day, is associated with an increased risk of death from pancreatic cancer, according to a report in the March 14 issue…
Study provides insight into why older adults are so vulnerable to pneumonia
A study featured on the cover of the March 15 Journal of Immunology is providing insight into why the elderly are so vulnerable to pneumonia and other bacterial infections. The study has…
Scientists show how E. coli strain causes infection in individuals
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown how the O157:H7 strain of Escherichia coli causes infection and thrives by…
Study: Statin use may reduce risk of high-grade prostate cancer
Men who take a certain class of cholesterol-lowering medicine, otherwise known as statins, may be 60 percent less likely to be diagnosed with high-grade prostate cancer. Some of the results of this…
New study: Two peptide agent combination might block tumor growth
A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumor blood vessels while also inhibiting the growth of tumor cells. This early test of…
New research: Fzd9 receptor can stimulate bone formation
New research shows that the Wnt receptor Frizzled-9 (Fzd9) promotes bone formation, providing a potential new target for the treatment of osteoporosis. The study appears online on March 14 in The Journal…
New findings may open doors for vaccine development against HIV, tuberculosis
Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary’s Faculty of Medicine…
ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB (formerly Tripep AB),…
New international research project to identify antibiotics against tuberculosis
Scientists are collaborating on a new international research project to identify antibiotics that can kill tuberculosis and fight resistant strains. “We want to accelerate the discovery of new compounds that can be…
Bayer receives FDA approval for Gadavist Injection
Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol) Injection, a macrocyclic gadolinium-based contrast agent (GBCA), for intravenous use in diagnostic magnetic resonance imaging…
Soya drinks vital for health: Expert
JEDDAH: Consuming soya foods has numerous beneficial effects for one’s health, a medical expert stressed at a scientific seminar held at the Kingdom Hospital in Riyadh recently. Dr. Mona Sanan, Consultant for…